The objective of this study was to collect and interpret three-axis acceleration, temperature, and relative humidity data from six locations within commercial transport trailers shipping market-weight pigs. Transport was observed in Kansas (n = 15) and North Carolina (n = 20). Prior to loading, three-axis accelerometers were affixed to six locations on the trailers: top fore (TF), top center (TC), top aft (TA), bottom fore (BF), bottom center (BC), and bottom aft (BA) compartments. Data were post-processed to calculate root-mean-square (RMS) accelerations and vibration dose values (VDV) in the vertical direction and the horizontal plane. These values were compared with exposure action values (EAV) and exposure limit values (ELV), vibration levels deemed uncomfortable and potentially dangerous to humans. Additionally, RMS and VDV were compared among the trailer compartments. The vertical RMS accelerations for all compartments exceeded the EAV for loads measured in Kansas, and for the majority of the compartments measured in North Carolina. Many compartments, specifically the BA compartment from all trips, exceeded the vertical ELV. Regardless of where the data were collected, fewer compartments exceeded the EAV in the horizontal orientation. Only BA compartments exceeded the ELV in the horizontal orientation. There were Area × Level interactions for vertical and horizontal RMS and VDV (P < 0.01). The BF compartment had a greater vertical RMS value than the TF, TC, and BC (P < 0.02) compartments, but did not differ (P = 0.06) from the TA compartment. The vertical RMS of the TA compartment did not differ from the TF, TC, and BC compartments (P > 0.13). The BF compartment had a greater (P = 0.02) vertical VDV value than the TC location, but did not differ from the other locations (P > 0.16). All other locations did not differ in vertical VDV (P > 0.12). The BF compartment had greater horizontal RMS than the TC and TA compartments (P < 0.01), but did not differ from TF and BC compartments (P > 0.12). All other compartments did not differ in horizontal RMS (P > 0.34). All compartments, aside from the BA compartment, did not differ in horizontal VDV (P > 0.19). Vibration analyses indicated the BA compartment had the greatest vertical and horizontal vibrations and a large percentage of the compartments exceed the EAV and ELV, which indicated pigs may have experienced uncomfortable trips that could cause discomfort or fatigue.

The objective of this study was to determine the daily dietary nicotinamide riboside (NR) dose required to maximize the delay of subjective muscle fatigue onset. Barrows (N = 100) were assigned to one of five treatments: a conventional swine finishing diet containing 0 (CON), 15 (15NR), 30 (30NR), 45 (45NR) mg·kg body weight⁻¹·d⁻¹ NR, or CON supplemented with 45 mg·kg body weight⁻¹·d⁻¹ NR by drench or cookie dough (DRE). All treatments were administered for the final 11 days of feeding. On supplementation d 10, barrows individually experienced a performance test at 1.09 m/s until they were subjectively exhausted. Wireless electromyography (EMG) sensors were affixed to the biceps femoris (BF), tensor fascia latae (TFL), and semitendinosus (ST) to measure real-time muscle activity. There were no treatment effects for barrow speed (p = 0.57), a tendency for a treatment effect (p = 0.07) for distance, and a treatment effect (p = 0.04) on time to exhaustion. Barrows of the 15NR and DRE treatments had greater (p = 0.05) distances to exhaustion than CON barrows but did not differ from other NR barrows (p > 0.11). Barrows in the 45NR treatment did not differ (p = 0.11) in distance from 30NR barrows but tended to have a greater (p = 0.07) distance compared to CON barrows. All other treatment comparisons did not differ (p > 0.27). Barrows in the DRE treatment moved for longer (p < 0.01) than CON barrows, but all other treatments did not differ from each other (p > 0.15). There was no treatment × period interaction for all muscles’ root mean square (RMS) values (p > 0.16), but there were Period effects for all muscles (p < 0.01) and a Treatment effect (p = 0.04) in the TFL. For all muscles, period 4 had greater RMS values than all other periods (p < 0.01), who did not differ from each other (p > 0.29). In the TFL, CON barrows had greater RMS values during the performance test compared to all NR treatments (p < 0.02), who did not differ from each other (p > 0.18). Overall, NR demonstrates potential in being a useful tool in fatigue prevention, but efficient administration of the compound needs further investigation.

Silicon appears to be an essential element for proper endochondral ossification and glycosaminoglycan synthesis. Osteochondrosis (OC) is characterized by disturbed endochondral ossification, and glycosaminoglycan loss has been reported in OC lesions. Therefore, silicon may be effective in reducing OC lesions. The objective of the study was to evaluate the effects of supplemental silicon on OC lesion size. Initial radiographs were taken on 2-year-old Standardbreds (n = 44) on private facilities to identify OC defects in the distal third metacarpus/tarsus or osteochondral fragments at the dorsal aspect of the joint and defects/fragments at the distal tibia and on the trochlear ridges of the talus. Only clinically sound horses were included. Follow-up radiographs were taken at 120 days. Radiographs were digitized and the length and height of the OC defects/fragments were measured. Horses meeting study-inclusion requirements (n = 8) were pair-matched by facility and affected joint(s) and assigned to a group: control (receiving 200 g whole grain flour) and silicon supplemented (receiving 200 g bioavailable silicon source). Treatments were top-dressed on the feed for 120 days. Due to the onset of lameness, four horses did not complete the 120-day study duration. There was no effect (P>0.22) of treatment, time or treatment × time on lesion length, height or area. Silicon supplementation did not alter the radiographic appearance of OC lesions. Future research should focus on the effects of a silicon supplement on the prevention of OC lesions.